Northwest Biotherapeutics (NWBO) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Northwest Biotherapeutics (NWBO) over the last 15 years, with Q3 2025 value amounting to -$0.02.
- Northwest Biotherapeutics' EPS (Weighted Average and Diluted) changed 0.0% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year increase of 1428.57%. This contributed to the annual value of -$68.58 for FY2024, which is 11419917.69% down from last year.
- Per Northwest Biotherapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.02 for Q3 2025, which was down 0.0% from -$0.01 recorded in Q2 2025.
- In the past 5 years, Northwest Biotherapeutics' EPS (Weighted Average and Diluted) ranged from a high of -$0.01 in Q4 2023 and a low of -$22.94 during Q4 2024
- For the 5-year period, Northwest Biotherapeutics' EPS (Weighted Average and Diluted) averaged around -$1.48, with its median value being -$0.02 (2021).
- In the last 5 years, Northwest Biotherapeutics' EPS (Weighted Average and Diluted) skyrocketed by 9979.76% in 2022 and then crashed by 22929261.99% in 2024.
- Northwest Biotherapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.02 in 2021, then fell by 0.0% to -$0.02 in 2022, then surged by 50.0% to -$0.01 in 2023, then crashed by 229292.62% to -$22.94 in 2024, then surged by 99.91% to -$0.02 in 2025.
- Its last three reported values are -$0.02 in Q3 2025, -$0.01 for Q2 2025, and -$0.01 during Q1 2025.